GCM
OGN icon

Glenview Capital Management’s Organon & Co OGN Stock Holding History

Glenview Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-753,127
Closed -$24.7M – 62
2021
Q3 		$24.7M Buy
+753,127
New +$24.1M 0.45% 47

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenview Capital Management's OGN Position: Q4 2021 in Review

Glenview Capital Management sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 753,127 shares — an estimated $24.7M sold.

Glenview Capital Management first reported a position in OGN in Q3 2021 and held it in 1 quarter. The position peaked at $24.7M in Q3 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • Glenview Capital Management reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
  • Glenview Capital Management sold 753,127 Organon & Co shares in Q4 2021, an estimated $24.7M.
  • Glenview Capital Management first reported a position in Organon & Co in Q3 2021 and held it in 1 quarter.
  • Glenview Capital Management's Organon & Co position peaked at $24.7M in Q3 2021.
  • 907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Glenview Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.